Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A silver lining on the horizon for glioblastoma.

× No keyword cloud information.

7 in total

1. Loss of 5-hydroxymethylcytosine and intratumoral heterogeneity as an epigenomic hallmark of glioblastoma.

Authors: Theo F J Kraus; Gesa Kolck; Andrea Greiner; Katharina Schierl; Virginie Guibourt; Hans A Kretzschmar
Journal: Tumour Biol Date: 2015-05-29

2. All-trans retinoic acid enhances temozolomide-induced autophagy in human glioma cells U251 via targeting Keap1/Nrf2/ARE signaling pathway.

Authors: Lin Shi; Hongyuan Li; Yang Zhan
Journal: Oncol Lett Date: 2017-06-27 Impact factor: 2.967

3. Targeted concurrent and sequential delivery of chemotherapeutic and antiangiogenic agents to the brain by using drug-loaded nanofibrous membranes.

Authors: Yuan-Yun Tseng; Tao-Chieh Yang; Yi-Chuan Wang; Wei-Hwa Lee; Tzu-Min Chang; Yi-Chuan Kau; Shih-Jung Liu
Journal: Int J Nanomedicine Date: 2017-02-14

4. A novel tumor suppressor protein encoded by circular AKT3 RNA inhibits glioblastoma tumorigenicity by competing with active phosphoinositide-dependent Kinase-1.

Authors: Xin Xia; Xixi Li; Fanying Li; Xujia Wu; Maolei Zhang; Huangkai Zhou; Nunu Huang; Xuesong Yang; Feizhe Xiao; Dawei Liu; Lixuan Yang; Nu Zhang
Journal: Mol Cancer Date: 2019-08-30 Impact factor: 27.401

A silver lining on the horizon for glioblastoma.

1. Loss of 5-hydroxymethylcytosine and intratumoral heterogeneity as an epigenomic hallmark of glioblastoma.

2. All-trans retinoic acid enhances temozolomide-induced autophagy in human glioma cells U251 via targeting Keap1/Nrf2/ARE signaling pathway.

3. Targeted concurrent and sequential delivery of chemotherapeutic and antiangiogenic agents to the brain by using drug-loaded nanofibrous membranes.

4. A novel tumor suppressor protein encoded by circular AKT3 RNA inhibits glioblastoma tumorigenicity by competing with active phosphoinositide-dependent Kinase-1.

Review 5. Protein tyrosine phosphatases in glioma biology.

Review 6. Targeting autophagy to sensitive glioma to temozolomide treatment.

Review 7. Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma.